ARHGAP35 and lung adenocarcinoma: Another intriguing discovery from cancer genome analyses is that in lung adenocarcinoma, ARHGAP35 alterations are found in tumor samples that lack mutations in genes encoding receptor tyrosine kinases (RTKs) or constituents of the RAS–ERK pathway [4].